Literature DB >> 15868322

Echocardiographic guidance of catheter-based treatments of atrial septal defect: transesophageal echocardiography remains the gold standard.

C S Kleinman1.   

Abstract

The availability of echocardiographic imaging to the catheterization laboratory has been recognized as an essential component of every congenital heart program for almost 30 years. The imaging data that are uniquely available using this technique may be used to plan the catheterization procedure; to add insights regarding valve anatomy and chordal insertions and myocardial performance; to assist in the identification of pericardial effusions; and to provide additional guidance for the performance of pericardiocentesis.

Entities:  

Mesh:

Year:  2005        PMID: 15868322     DOI: 10.1007/s00246-004-0957-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Selection of patients with secundum atrial septal defects for transcatheter device closure.

Authors:  S A Qureshi
Journal:  Eur Heart J       Date:  2000-04       Impact factor: 29.983

2.  Phased-array intracardiac echocardiography for guiding transseptal catheter placement: utility and learning curve.

Authors:  Susan B Johnson; James B Seward; Douglas L Packer
Journal:  Pacing Clin Electrophysiol       Date:  2002-04       Impact factor: 1.976

3.  Incidence of complications in pediatric transesophageal echocardiography: experience in 1650 cases.

Authors:  J G Stevenson
Journal:  J Am Soc Echocardiogr       Date:  1999-06       Impact factor: 5.251

4.  Two- and three-dimensional transesophageal echocardiography in patient selection and assessment of atrial septal defect closure by the new DAS-Angel Wings device: initial clinical experience.

Authors:  G Magni; Z M Hijazi; N G Pandian; A Delabays; L Sugeng; C Laskari; G R Marx
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

5.  Nonoperative closure of atrial septal defects.

Authors:  T D King; N L Mills
Journal:  Surgery       Date:  1974-03       Impact factor: 3.982

6.  The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder.

Authors:  U Mazic; P Gavora; J Masura
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

7.  Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders.

Authors:  T Podnar; P Martanovic; P Gavora; J Masura
Journal:  Catheter Cardiovasc Interv       Date:  2001-07       Impact factor: 2.692

8.  Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications.

Authors:  Thomas Bartel; Thomas Konorza; Jawed Arjumand; Tiko Ebradlidze; Holger Eggebrecht; Guido Caspari; Ulrich Neudorf; Raimund Erbel
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

9.  Transthoracic echocardiographic guidance of transcatheter atrial septal defect closure.

Authors:  Richard E Kardon; Mary C Sokoloski; Daniel S Levi; James S Perry; Douglas J Schneider; Vivekanand Allada; John W Moore
Journal:  Am J Cardiol       Date:  2004-07-15       Impact factor: 2.778

10.  Transesophageal echocardiographic guidance of transcatheter closure of atrial septal defect.

Authors:  W E Hellenbrand; J T Fahey; F X McGowan; G G Weltin; C S Kleinman
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

View more
  2 in total

1.  Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography?

Authors:  Kiran Mallula; Zahid Amin
Journal:  Pediatr Cardiol       Date:  2012-05-11       Impact factor: 1.655

2.  Evaluation of morphological characteristics of septal rims affecting successful transcatheter atrial septal defect closure in children and adults.

Authors:  Mehmet Burhan Oflaz; Feyza Aysenur Pac; Ayse Esin Kibar; Sevket Balli; Ibrahim Ece
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-09-16       Impact factor: 1.426

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.